Literature DB >> 11154051

Honokiol and magnolol increased hippocampal acetylcholine release in freely-moving rats.

Y C Hou1, P D Chao, S Y Chen.   

Abstract

Honokiol and magnolol, phenolic compounds isolated from the stem bark of Magnolia officinalis, have been demonstrated to increase choline acetyltransferase activity, inhibit acetylcholinesterase, promote potassium-induced acetylcholine release and exhibit neurotrophic function in in vitro studies. The objective of the present study was to determine the effect of these compounds on hippocampal acetylcholine release in conscious, freely-moving rats. 10(-4) M-10(-6) M of honokiol or magnolol was perfused into rat hippocampus via a dialysis probe. The results showed that at 10(-4) M concentration, honokiol and magnolol markedly increased extracellular acetylcholine release to 165.5+/-5.78% and 237.83+/-9.47% of the basal level, respectively. However, lower concentrations of either compounds failed to elicit significant acetylcholine release. This result suggests that a high dose of honokiol or magnolol may enhance in vivo hippocampal acetylcholine release.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11154051     DOI: 10.1142/S0192415X00000441

Source DB:  PubMed          Journal:  Am J Chin Med        ISSN: 0192-415X            Impact factor:   4.667


  6 in total

1.  Magnolol, a major bioactive constituent of the bark of Magnolia officinalis, exerts antiepileptic effects via the GABA/benzodiazepine receptor complex in mice.

Authors:  C R Chen; R Tan; W M Qu; Z Wu; Y Wang; Y Urade; Z L Huang
Journal:  Br J Pharmacol       Date:  2011-11       Impact factor: 8.739

2.  The natural products magnolol and honokiol are positive allosteric modulators of both synaptic and extra-synaptic GABA(A) receptors.

Authors:  Mikhail Alexeev; Denise K Grosenbaugh; David D Mott; Janet L Fisher
Journal:  Neuropharmacology       Date:  2012-03-12       Impact factor: 5.250

Review 3.  Effects of medicinal plants on Alzheimer's disease and memory deficits.

Authors:  Muhammad Akram; Allah Nawaz
Journal:  Neural Regen Res       Date:  2017-04       Impact factor: 5.135

Review 4.  Alzheimer's disease treatment: The share of herbal medicines.

Authors:  Masoud Soheili; Mohammad Karimian; Gholamali Hamidi; Mahmoud Salami
Journal:  Iran J Basic Med Sci       Date:  2021-02       Impact factor: 2.699

5.  Protective effect of the ethanol extract of Magnolia officinalis and 4-O-methylhonokiol on scopolamine-induced memory impairment and the inhibition of acetylcholinesterase activity.

Authors:  Yong Kyung Lee; Dong Yeon Yuk; Tae Il Kim; Young Heui Kim; Kyoung Tae Kim; Ki Ho Kim; Beom Jun Lee; Sang-Yoon Nam; Jin Tae Hong
Journal:  J Nat Med       Date:  2009-04-04       Impact factor: 2.343

6.  A Comparison between Extract Products of Magnolia officinalis on Memory Impairment and Amyloidogenesis in a Transgenic Mouse Model of Alzheimer's Disease.

Authors:  Young-Jung Lee; Dong-Young Choi; Sang Bae Han; Young Hee Kim; Ki Ho Kim; Yeon Hee Seong; Ki-Wan Oh; Jin Tae Hong
Journal:  Biomol Ther (Seoul)       Date:  2012-05       Impact factor: 4.634

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.